Literature DB >> 19465942

Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients.

M Ogata1, T Satou, R Kawano, S Takakura, K Goto, J Ikewaki, K Kohno, T Ikebe, T Ando, Y Miyazaki, E Ohtsuka, Y Saburi, T Saikawa, J Kadota.   

Abstract

This study investigated factors associated with the development of human herpesvirus (HHV)-6 encephalitis. Among 111 enrolled subjects, 12 patients developed central nervous system (CNS) dysfunction. CNS dysfunction in four patients was found to have no association with HHV-6. The remaining eight patients displayed HHV-6 encephalitis (n=3), limbic encephalitis (HHV-6 DNA in cerebrospinal fluid was not examined; n=3) or CNS dysfunction because of an unidentified cause (n=2). Real-time PCR showed CNS dysfunction in the latter eight patients, which developed concomitant with the appearance of high plasma levels of HHV-6 DNA (> or =10(4) copies/ml). Overall, eight of the 24 patients with high-level HHV-6 DNA developed CNS dysfunction, whereas no patients developed CNS dysfunction potentially associated with HHV-6 infection if peak HHV-6 DNA was <10(4) copies/ml. We next analyzed plasma concentrations of IL-6, IL-10 and tumor necrosis factor-alpha among patients who displayed high-level plasma HHV-6 DNA and found elevated IL-6 concentrations preceding HHV-6 infection in patients who developed CNS dysfunction. (Mean+/-s.d.: 865.7+/-1036.3 pg/ml in patients with CNS dysfunction; 56.5+/-192.9 pg/ml in others; P=0.01). These results suggest that high-level HHV-6 load is necessary for the development of HHV-6 encephalitis, and systemic inflammatory conditions before HHV-6 infection form the preparatory conditions for progression to encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19465942     DOI: 10.1038/bmt.2009.116

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  22 in total

1.  HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation.

Authors:  Danielle M Zerr; Michael Boeckh; Colleen Delaney; Paul J Martin; Hu Xie; Amanda L Adler; Meei-Li Huang; Lawrence Corey; Wendy M Leisenring
Journal:  Biol Blood Marrow Transplant       Date:  2012-05-26       Impact factor: 5.742

2.  Graft failure in cord blood transplantation successfully treated with short-term reduced-intensity conditioning regimen and second allogeneic transplantation.

Authors:  Masahiko Sumi; Ikuo Shimizu; Keijiro Sato; Toshimitsu Ueki; Daigo Akahane; Mayumi Ueno; Naoaki Ichikawa; Shinji Nakao; Hikaru Kobayashi
Journal:  Int J Hematol       Date:  2010-11-05       Impact factor: 2.490

Review 3.  Human inborn errors of immunity to herpes viruses.

Authors:  Emmanuelle Jouanguy; Vivien Béziat; Trine H Mogensen; Jean-Laurent Casanova; Stuart G Tangye; Shen-Ying Zhang
Journal:  Curr Opin Immunol       Date:  2020-01-31       Impact factor: 7.486

4.  A 16-year-old transplant patient with amnesia, insomnia, and visual hallucinations.

Authors:  Jerome J Graber; Nancy A Kernan; Yasmin Khakoo
Journal:  Neurol Clin Pract       Date:  2014-02

5.  RNA Sequencing of the In Vivo Human Herpesvirus 6B Transcriptome To Identify Targets for Clinical Assays Distinguishing between Latent and Active Infections.

Authors:  Joshua A Hill; Minako Ikoma; Danielle M Zerr; Ryan S Basom; Vikas Peddu; Meei-Li Huang; Ruth Hall Sedlak; Keith R Jerome; Michael Boeckh; Serge Barcy
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

6.  Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation.

Authors:  M Ogata; K Oshima; T Ikebe; K Takano; H Kanamori; T Kondo; Y Ueda; T Mori; H Hashimoto; H Ogawa; T Eto; T Ueki; T Miyamoto; T Ichinohe; Y Atsuta; T Fukuda
Journal:  Bone Marrow Transplant       Date:  2017-08-07       Impact factor: 5.483

7.  Detection of donor-derived CMV-specific T cells in cerebrospinal fluid in a case of CMV meningoencephalitis after cord blood stem cell transplantation.

Authors:  Kazuhiro Ikegame; Ruri Kato; Tatsuya Fujioka; Masaya Okada; Katsuji Kaida; Shinichi Ishii; Satoshi Yoshihara; Takayuki Inoue; Kyoko Taniguchi; Hiroya Tamaki; Toshihiro Soma; Hiroyasu Ogawa
Journal:  Int J Hematol       Date:  2012-12-29       Impact factor: 2.490

Review 8.  Opportunistic infections of the central nervous system in the transplant patient.

Authors:  Bruce A Cohen; Valentina Stosor
Journal:  Curr Neurol Neurosci Rep       Date:  2013-09       Impact factor: 5.081

Review 9.  Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know.

Authors:  M Ogata; T Fukuda; T Teshima
Journal:  Bone Marrow Transplant       Date:  2015-04-27       Impact factor: 5.483

Review 10.  Viral myocarditis: from experimental models to molecular diagnosis in patients.

Authors:  Sabine Pankuweit; Karin Klingel
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.